Optimizing Navigation to Successful Colorectal Cancer Screening
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02192034|
Recruitment Status : Completed
First Posted : July 16, 2014
Last Update Posted : October 28, 2015
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer Screening||Behavioral: Navigation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||156 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Optimizing Navigation to Successful Colorectal Cancer Screening|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||April 2014|
|Actual Study Completion Date :||June 2014|
Experimental: Navigation Group
This group will receive standard clinic instructions for the colonoscopy and two additional phone calls from the patient navigator to discuss the purpose, preparation, and additional information regarding the colonoscopy procedure.
Placebo Comparator: Control
This group will receive only clinic instructions without intervention from the patient navigator.
- Navigation role in colorectal cancer screening [ Time Frame: Up to 90 days ]Primary endpoint will be the role of navigation to obtain colonoscopy attendance with adequate colonoscopy preparation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02192034
|United States, Illinois|
|Rush University Medical Center|
|Chicago, Illinois, United States, 60612|
|Principal Investigator:||Joshua E Melson, MD, MPH||Rush University Medical Center|